FDA inspection
Rosemont Pharmaceuticals Ltd.: FDA inspection ending Dec 12, 2014
FDA inspection 906518 · Voluntary Action Indicated (VAI) · Leeds
Key facts
| Inspection ID | 906518 |
|---|---|
| Firm | Rosemont Pharmaceuticals Ltd. |
| FEI number | 3002442738 |
| Address | Rosemont House, Yorkdale Industrial Park |
| City | Leeds |
| Country | United Kingdom |
| Fiscal year | 2015 |
| Inspection end date | Dec 12, 2014 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data